Investigation of Metabolomics Differences Between Metabolic Syndrome and Healthy Individuals in Taiwan - Trial NCT06363864
Access comprehensive clinical trial information for NCT06363864 through Pure Global AI's free database. This phase not specified trial is sponsored by Leeuwenhoek Laboratories Co. Ltd. and is currently Not yet recruiting. The study focuses on Metabolic Syndrome. Target enrollment is 1200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Leeuwenhoek Laboratories Co. Ltd.
Timeline & Enrollment
N/A
Apr 14, 2024
Oct 31, 2029
Primary Outcome
Concentration changes of small molecules in blood.
Summary
The prevalence of metabolic syndrome in Taiwan has been increasing yearly. In this project,
 the database of blood test results from healthy and metabolic syndromes individuals will be
 analyzed to identify the small molecules related to the severity of metabolic syndrome. These
 identified small molecules could be used as biomarkers to predict the development of
 metabolic syndromes in the future.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06363864
Non-Device Trial